CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $1,233,534
- in 4 filings
Net −$664,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series A-3 Redeemable Convertible Preferred Stock | −468,321 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series C Redeemable Convertible Preferred Stock | −5,446,902 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series E Redeemable Convertible Preferred Stock | −53,251,030 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series F Redeemable Convertible Preferred Stock | −6,895,096 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series F Redeemable Convertible Preferred Stock | −262,821 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series F Redeemable Convertible Preferred Stock | −833,333 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series F Redeemable Convertible Preferred Stock | −81,166,226 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series H Redeemable Convertible Preferred Stock | −742,761 | 0 | ||
| 2019-09-23 | TULLIS JAMES L L Director | Conversion · Series H Redeemable Convertible Preferred Stock | −58,359,932 | 0 | ||
| 2019-09-23 | H.I.G. Bio-Exagen, L.P. 10% owner | Conversion | +1,271,252 | 1,271,252 | ||
| 2019-09-23 | H.I.G. Bio-Exagen, L.P. 10% owner | Purchase | +425,000 | $14.00 | $6.0M | 1,696,252 |
| 2019-09-23 | H.I.G. Bio-Exagen, L.P. 10% owner | Conversion · Series H Redeemable Convertible Preferred Stock | −233,446,519 | 0 | ||
| 2019-09-19 | TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner | Option exercise | +11,498 | $14.32 | $165K | 11,597 |
| 2019-09-19 | TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner | Shares withheld for taxes | −8,865 | $18.58 | $165K | 2,732 |
| 2019-09-19 | TULLIS DICKERSON CAPITAL FOCUS III, L.P. 10% owner | Option exercise · Warrants | −11,498 | $14.32 | $165K | 0 |
| 2019-09-19 | Hunt Holdings Limited Partnership 10% owner | Option exercise | +202,011 | $1.84 | $372K | 202,727 |
| 2019-09-19 | Hunt Holdings Limited Partnership 10% owner | Option exercise | +10,557 | $14.32 | $151K | 213,284 |
| 2019-09-19 | Hunt Holdings Limited Partnership 10% owner | Shares withheld for taxes | −28,106 | $18.58 | $522K | 185,178 |
| 2019-09-19 | Hunt Holdings Limited Partnership 10% owner | Conversion · Warrants | −170,093 | $1.84 | $313K | 0 |
| 2019-09-19 | Hunt Holdings Limited Partnership 10% owner | Conversion · Warrants | −31,918 | $1.84 | $59K | 0 |
Page 11 of 12 · 239 trades